Skip to Content

Sihuan Pharmaceutical Holdings Group Ltd SHPHF Stock Quote

| Rating as of


Last close prices updated as of May 31, 2023, 11:12 AM EST | USD
  • Last Close 0.10
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Mid Value
  • Day Range 0.10  –  0.10
  • Year Range 0.07  –  0.17
  • Market Cap 895.6799 Mil
  • Volume / Avg 50,000.0 /  20,372.8
  • Price / Sales 2.92
  • Price / Book 1.34
  • Forward Div Yield 5.04%
  • Trailing Div Yield 177.08%

Morningstar‘s Stock Analysis SHPHF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics SHPHF

Company Profile SHPHF

Business Description

Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.

Zhubang 2000 Business Centre, 22nd Floor, Building 4, West Balizhuang, Chaoyang District
Beijing, 100025, CHN
Industry Drug Manufacturers - Specialty & Generic
Employees 3,313

Competitors & Peers SHPHF

Morningstar does not cover competitors or peers for this firm.

FAQs for Sihuan Pharmaceutical Holdings Group Ltd Stock

Yes. SHPHF has a forward dividend yield of 0.13%. See SHPHF’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

SHPHF’s market cap is 895.68 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

SHPHF’s stock style is Mid Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

SHPHF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare SHPHF’s historical performance against its industry peers and the overall market.